August 11, 2025

FDA Approves Ketamine Product for Surgical Pain Management

PharmaTher has received FDA approval for KETARx, a ketamine therapy for surgical pain management.

Conexiant

August 08, 2025

Genetic Risk of Takayasu Arteritis Mapped

Large-scale genetic analyses identify multiple susceptibility loci for Takayasu arteritis, confirming HLA-B*52 as the strongest association and revealing immune pathways that vary by ancestry.

Conexiant

August 08, 2025

Unprompted Speech Changes Found in ME/CFS

Nearly 1 in 10 individuals with myalgic encephalomyelitis/chronic fatigue syndrome reported voice or speech changes in a recent survey, despite not being directly asked about these symptoms.

Conexiant

August 05, 2025

Cannabis Use Common Among Adolescents With Chronic Pain, Study Finds

Researchers found that one in four adolescents with chronic pain reported lifetime cannabis use.

Conexiant

August 04, 2025

Acupuncture Review Targets IgA Vasculitis Pain

Researchers will systematically review the efficacy and safety of acupuncture for abdominal pain in IgA vasculitis, aiming to inform clinical practice.

Conexiant

April 29, 2024

A Look Ahead at Rheumatology in 2024

A rheumatologist reflected on rheumatology developments in 2023 and looked ahead to the developments and challenges the field may face in 2024.

Conexiant

April 30, 2024

Potential New Lyme Disease Therapy Advances to Human Safety Trials

The novel antibiotic therapy hygromycin A has advanced to human safety trials to determine its potential as a future treatment for Lyme disease.

Conexiant

April 29, 2024

Methotrexate Response in Patients With Juvenile Idiopathic Arthritis

A machine-learning model may help predict how patients with juvenile idiopathic arthritis respond to treatment with methotrexate.

Conexiant

November 18, 2024

Apocrine Gland Changes in Early Hidradenitis Suppurativa

A recent study in the Journal of Investigative Dermatology identified potential early factors in the development of hidradenitis suppurativa, involving apocrine gland damage and keratin release, offering insights into potential biomarkers for disease severity and progression.

Conexiant